What is already known? CGM is underutilized in low- and middle-income countries (LMICs). Earlier results from the CAPT1D study suggest that CGM can rapidly improve glycaemic parameters in Rwandans with type 1 diabetes. What has this study found? Improvements in HbA1c and time in range were sustained for up to 2 years with minimal supervision; however, time below range and glycaemic variability increased. Participants were satisfied with the technology and used it consistently.
Sandhya Narayanan
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Sandhya
Contact Sandhya, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack